These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 16987898

  • 1. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.
    Chan WM, Lai TY, Wong AL, Liu DT, Lam DS.
    Br J Ophthalmol; 2007 Feb; 91(2):174-9. PubMed ID: 16987898
    [Abstract] [Full Text] [Related]

  • 2. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.
    Chan WM, Lai TY, Wong AL, Tong JP, Liu DT, Lam DS.
    Br J Ophthalmol; 2006 Mar; 90(3):337-41. PubMed ID: 16488958
    [Abstract] [Full Text] [Related]

  • 3. Photodynamic therapy combined with posterior subtenon triamcinolone acetonide injection in the treatment of choroidal neovascularization.
    Lee YA, Ho TC, Chen MS, Yang CH, Yang CM.
    Eye (Lond); 2009 Mar; 23(3):645-51. PubMed ID: 18292791
    [Abstract] [Full Text] [Related]

  • 4. Photodynamic therapy with or without intravitreal triamcinolone acetonide for symptomatic polypoidal choroidal vasculopathy.
    Lai TY, Lam CP, Luk FO, Chan RP, Chan WM, Liu DT, Lam DS.
    J Ocul Pharmacol Ther; 2010 Feb; 26(1):91-5. PubMed ID: 20148658
    [Abstract] [Full Text] [Related]

  • 5. Combined photodynamic therapy and intravitreal triamcinolone for choroidal neovascularization secondary to punctate inner choroidopathy or of idiopathic origin: one-year results of a prospective series.
    Chan WM, Lai TY, Lau TT, Lee VY, Liu DT, Lam DS.
    Retina; 2008 Jan; 28(1):71-80. PubMed ID: 18185141
    [Abstract] [Full Text] [Related]

  • 6. Comparison of intravitreal triamcinolone acetonide with photodynamic therapy and intravitreal bevacizumab with photodynamic therapy for retinal angiomatous proliferation.
    Saito M, Shiragami C, Shiraga F, Kano M, Iida T.
    Am J Ophthalmol; 2010 Mar; 149(3):472-81.e1. PubMed ID: 20053392
    [Abstract] [Full Text] [Related]

  • 7. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.
    Chaudhary V, Mao A, Hooper PL, Sheidow TG.
    Ophthalmology; 2007 Dec; 114(12):2183-9. PubMed ID: 18054638
    [Abstract] [Full Text] [Related]

  • 8. Combined photodynamic therapy and intravitreal triamcinolone acetonide for the treatment of myopic subfoveal choroidal neovascularization.
    Marticorena J, Gomez-Ulla F, Fernandez M, Pazos B, Rodriguez-Cid MJ, Sanchez-Salorio M.
    Am J Ophthalmol; 2006 Aug; 142(2):335-7. PubMed ID: 16876524
    [Abstract] [Full Text] [Related]

  • 9. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study.
    Chan WM, Lai TY, Liu DT, Lam DS.
    Br J Ophthalmol; 2009 Feb; 93(2):150-4. PubMed ID: 18801766
    [Abstract] [Full Text] [Related]

  • 10. Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients.
    Frimpong-Boateng A, Bunse A, Rüfer F, Roider J.
    Acta Ophthalmol; 2009 Mar; 87(2):183-7. PubMed ID: 18547278
    [Abstract] [Full Text] [Related]

  • 11. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.
    Chan WM, Lai TY, Liu DT, Lam DS.
    Ophthalmology; 2007 Dec; 114(12):2190-6. PubMed ID: 17599414
    [Abstract] [Full Text] [Related]

  • 12. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
    Arias L, Garcia-Arumi J, Ramon JM, Badia M, Rubio M, Pujol O.
    Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
    [Abstract] [Full Text] [Related]

  • 13. FACTORS INFLUENCING NEED FOR RETREATMENT AND LONG-TERM VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
    Ng DS, Kwok AK, Tong JM, Chan CW, Li WW.
    Retina; 2015 Dec; 35(12):2457-68. PubMed ID: 26035400
    [Abstract] [Full Text] [Related]

  • 14. Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy.
    Hayashi K, Ohno-Matsui K, Teramukai S, Shimada N, Moriyama M, Hayashi W, Yoshida T, Tokoro T, Mochizuki M.
    Am J Ophthalmol; 2009 Sep; 148(3):396-408. PubMed ID: 19427991
    [Abstract] [Full Text] [Related]

  • 15. Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.
    Ahmadieh H, Taei R, Soheilian M, Riazi-Esfahani M, Karkhaneh R, Lashay A, Azarmina M, Dehghan MH, Moradian S.
    BMC Ophthalmol; 2007 Jun 07; 7():10. PubMed ID: 17555600
    [Abstract] [Full Text] [Related]

  • 16. Intravitreal bevacizumab vs sub-tenon triamcinolone acetonide for choroidal neovascularization attributable to pathologic myopia.
    Wakabayashi T, Ikuno Y, Gomi F, Hamasaki T, Tano Y.
    Am J Ophthalmol; 2009 Oct 07; 148(4):591-596.e1. PubMed ID: 19589497
    [Abstract] [Full Text] [Related]

  • 17. Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia.
    Yamamoto I, Rogers AH, Reichel E, Yates PA, Duker JS.
    Br J Ophthalmol; 2007 Feb 07; 91(2):157-60. PubMed ID: 16870653
    [Abstract] [Full Text] [Related]

  • 18. Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome.
    Ruiz-Moreno JM, Montero JA, Barile S, Zarbin MA.
    Retina; 2006 Feb 07; 26(6):602-12. PubMed ID: 16829800
    [Abstract] [Full Text] [Related]

  • 19. Intravitreous bevacizumab to treat subfoveal choroidal neovascularization in highly myopic eyes: short-term results.
    Ruiz-Moreno JM, Gomez-Ulla F, Montero JA, Ares S, Lopez-Lopez F, Rodriguez M, Fernandez M.
    Eye (Lond); 2009 Feb 07; 23(2):334-8. PubMed ID: 18064056
    [Abstract] [Full Text] [Related]

  • 20. Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome.
    Ruiz-Moreno JM, Montero JA, Gomez-Ulla F, Ares S.
    Br J Ophthalmol; 2009 Apr 07; 93(4):448-51. PubMed ID: 19091851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.